To systematically evaluate the epidemiological association between serum insulin-like growth factor-1 (IGF-I) levels and the risk of prostate cancer, in order to provide evidence-based support for risk stratification and early prevention of prostate cancer. The gene discussed is IGF1; the disease is Familial prostate cancer.